ARGX241220P780000
- 0.00
- 0.000.00%
argenx SE Newsroom
Here's Why Argenx SE (ARGX) Surged in Q3
Citi Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $681
Citi Reaffirms Their Buy Rating on Argenx Se (ARGX)
Looking Into Argenx's Recent Short Interest
Should You Increase Your Holdings in Argenx SE (ARGX)?
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading
European Stocks Will See Downtrend Mid-year 2025 Before Recovery
Express News | Argenx SE : JP Morgan Raises Target Price to $770 From $670
Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now?
Argenx to Present at Upcoming Investor Conferences
Argenx Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $706
Oppenheimer Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $675
Jefferies Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $689
Jefferies Sticks to Their Buy Rating for Argenx Se (ARGX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $606 to $770
Express News | Argenx SE : Raymond James Raises Target Price to $770 From $688
Argenx Se's Promising Clinical Advancements and Positive ALKIVIA Study Results Underpin Buy Rating
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
Sector Update: Health Care Stocks Edge Higher Premarket Wednesday